Recital 4, Regulation (EU) 2022/315

In forcesince 17 Dec 2021

The withdrawal of the United Kingdom from the Union would, in the absence of a derogation from the applicable rules, have had the effect that unique identifiers must be decommissioned for medicinal products intended to be distributed in the United Kingdom except Northern Ireland.